My brain fog in the afternoons made it hard to focus on work
Regulatory Frameworks and Supply Dynamics: In December 2025, the FDA approved the first oral GLP-1 for weight loss-Novo Nordisk's once-daily semaglutide pill, which launched in January 2026, significantly expanding accessibility for patients averse to injections [3]
Packing a massive 40g serving size, this giant delivers city-crushing pumps, razor sharp focus &
Small pilot studies that demonstrated a short lived and small improvement in one autism measure, also led to some side effects, including rash only in those receiving suramin
Then there are the known side effects of GLP-1s
It has also been found to scavenge free radicals and promote cytokine balance, which helps maintain normal inflammatory balance